Women's health technology company Kindara has had another executive shakeup, naming a new CEO, CTO, and EVP. The new CEO, Ira Hernowitz, previously served as president of children's footwear company Stride Rite. The company also announced a new Chief Technology Officer, Malte Muenke, and a new EVP, Raychel Muenke, both of whom previously worked at Citrix.
“The newly appointed members of Kindara’s executive leadership team are three incredibly accomplished experts in their respective fields,” Nicole Strata, founder and managing director of Boston Seed Capital, which recently led a $700,000 seed round in Kindara, said in a statement. “Kindara is poised for continued growth and expansion under Ira, Malte and Raychel’s collective guidance. The growth of WaaS (Wellness as a Service) bodes well for Kindara given the combined experience of the team.”
Although the company just announced the new hires, their LinkedIn profiles show that Hernowitz started in May, just two months after Denise Franklin took over as CEO in March. A spokesperson told MobiHealthNews that she stepped down to pursue other opportunities and that Hernowitz was serving as interim CEO up until now.
In-home senior care company HomeTeam announced another new hire recently: Chief Marketing Officer Andrew Chomer. Chomer was previously executive vice president of sales and marketing at digital-enabled house call company Pager.
"Hometeam is thrilled to have Andrew join us as the chief marketing officer,” Josh Bruno, cofounder and CEO of Hometeam, said in a statement. “Our vision is simple: redefine aging in America. As Hometeam continues to grow, we recognize the need to bring in top talent to deliver our customer-centric marketing strategy. Andrew brings a passion for our mission, and we’re excited to have his energy take us to the next level.”
NovioSense, which is working on disrupting the glucose monitoring space with a sensor placed in the lower eyelid, hired Harry G. Mitchell as its new EVP of business development. Mitchell is no stranger to the space.
"Through his finance and C-Level experience, Mr. Mitchell is a leading business developer in the medical device and diabetes space, and was recently cofounder of Joslin Institute for Technology Translation at the Joslin Diabetes Center in Boston, Massachusetts," NovioSense CEO Dr Christopher Wilson said in a statement. "Throughout his career, Harry has focused on building companies through M&A and publically traded initiatives. We are excited to have Harry on board as we continue to grow and explore several product opportunities using our analyte sensing portfolio."
When women's health technology and maternity benefits company Ovia Health announced its $10 million funding round earlier this month, the company also anounced that it had hired Greg Nash, former VP of sales at Castlight and Omada, as the head of benefits products. In fact, CEO Paris Wallace told MobiHealthNews that the funding will primarily go to building out Nash's team.
"We’re using the majority of the funding to work with him to build his team to really help us grow the business in the employer and insurer markets, as well as increasing our clinical footprint … and really thinking about what our provider strategy is and beginning to execute on that," he said.
